URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Joseph Roscoe

Concepts (267)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
31
1998
155
8.780
Why?
Antineoplastic Agents
27
1998
628
4.440
Why?
Vomiting
17
1998
116
3.800
Why?
Neoplasms
30
1998
743
3.440
Why?
Acupressure
5
2002
15
2.880
Why?
Antineoplastic Combined Chemotherapy Protocols
12
1986
436
2.850
Why?
Fatigue
15
2001
124
2.560
Why?
Breast Neoplasms
19
1986
666
2.490
Why?
Antiemetics
12
1998
55
2.000
Why?
Vomiting, Anticipatory
7
1998
21
1.770
Why?
Acupuncture Therapy
4
2002
12
1.430
Why?
Sleep Disorders
4
2002
70
1.360
Why?
Doxorubicin
7
2003
105
1.170
Why?
Middle Aged
44
1986
10013
1.150
Why?
Radiotherapy
5
2002
198
1.050
Why?
Aged
35
1989
7392
1.050
Why?
Adult
35
1986
11572
0.950
Why?
Female
47
1986
20222
0.920
Why?
Humans
65
1986
37165
0.870
Why?
Depression
5
2001
442
0.850
Why?
Attitude
2
2000
67
0.840
Why?
Cisplatin
3
2000
93
0.800
Why?
Sleep
1
2011
58
0.790
Why?
Carboplatin
2
2003
29
0.740
Why?
Quality of Life
12
1998
528
0.710
Why?
Cyclohexanecarboxylic Acids
3
2003
46
0.700
Why?
Amines
3
2003
63
0.700
Why?
Wrist
3
2002
49
0.690
Why?
Cerebral Cortex
1
2011
257
0.690
Why?
gamma-Aminobutyric Acid
3
2003
97
0.680
Why?
Paroxetine
2
2003
10
0.640
Why?
Hot Flashes
2
2004
25
0.610
Why?
Fatigue Syndrome, Chronic
1
2007
11
0.600
Why?
Acetates
2
2003
65
0.580
Why?
Serotonin Antagonists
4
1998
21
0.570
Why?
Patient Education as Topic
6
2000
227
0.570
Why?
Psychophysiology
1
2006
15
0.560
Why?
Community Health Centers
2
2000
30
0.560
Why?
Aged, 80 and over
17
1989
2588
0.540
Why?
Prochlorperazine
3
2005
11
0.540
Why?
Transcutaneous Electric Nerve Stimulation
1
2005
7
0.530
Why?
Therapeutic Touch
1
2005
3
0.530
Why?
Male
31
1989
20139
0.530
Why?
Antidepressive Agents, Second-Generation
1
2005
13
0.520
Why?
Treatment Outcome
14
1998
2671
0.510
Why?
Behavior
1
2004
54
0.500
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.490
Why?
Physical Stimulation
1
2003
56
0.470
Why?
Tamoxifen
1
2004
84
0.460
Why?
Radiation Injuries
1
2005
131
0.460
Why?
Academic Medical Centers
2
2003
94
0.460
Why?
Double-Blind Method
7
2003
996
0.450
Why?
Behavior Therapy
4
1998
110
0.440
Why?
Electroacupuncture
1
2002
2
0.440
Why?
Benzhydryl Compounds
3
2005
13
0.400
Why?
Outcome Assessment (Health Care)
1
2003
301
0.380
Why?
Health Knowledge, Attitudes, Practice
3
2000
296
0.370
Why?
Severity of Illness Index
6
2000
943
0.320
Why?
Complementary Therapies
2
2006
39
0.320
Why?
Continental Population Groups
2
1997
125
0.320
Why?
Questionnaires
8
2000
1061
0.320
Why?
Peritoneum
1
1997
13
0.310
Why?
Urea
1
1997
56
0.310
Why?
Kidney Failure, Chronic
2
1997
119
0.310
Why?
Peritoneal Dialysis
1
1997
20
0.310
Why?
Granisetron
2
1998
7
0.300
Why?
Adaptation, Psychological
2
2006
212
0.300
Why?
Perception
3
2004
66
0.290
Why?
Patient Satisfaction
3
2004
243
0.280
Why?
Ondansetron
2
1998
11
0.240
Why?
Risk Factors
3
2000
2331
0.240
Why?
Drug Administration Schedule
3
1989
374
0.240
Why?
Dexamethasone
2
2005
188
0.230
Why?
Relaxation Therapy
2
2007
15
0.230
Why?
Activities of Daily Living
2
2001
273
0.220
Why?
Receptors, Neurokinin-1
1
2012
7
0.220
Why?
Quinuclidines
1
2012
6
0.220
Why?
Intention to Treat Analysis
1
2012
10
0.220
Why?
Age Factors
4
2004
1152
0.220
Why?
Morpholines
1
2012
43
0.220
Why?
Pain
2
2006
392
0.220
Why?
Isoquinolines
1
2012
63
0.220
Why?
Professional Role
1
2012
22
0.210
Why?
Polysomnography
1
2011
25
0.210
Why?
Ginger
1
2011
5
0.210
Why?
Oral Health
1
2012
42
0.200
Why?
Mouth Diseases
1
2012
47
0.200
Why?
Phytotherapy
1
2011
18
0.200
Why?
Psychology, Medical
1
2011
2
0.200
Why?
Drug Therapy, Combination
1
2012
397
0.200
Why?
Cyclophosphamide
3
2003
177
0.200
Why?
Suggestion
1
2010
6
0.190
Why?
Benzodiazepines
1
2010
26
0.190
Why?
Conditioning, Classical
1
2010
36
0.190
Why?
Self Efficacy
1
2011
49
0.190
Why?
Receptors, Serotonin, 5-HT3
3
1998
8
0.190
Why?
Dentate Gyrus
1
2010
26
0.190
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Clinical Trials as Topic
4
1989
685
0.180
Why?
Serotonin 5-HT3 Receptor Antagonists
2
2004
7
0.180
Why?
Information Seeking Behavior
1
2009
3
0.180
Why?
Pilot Projects
3
2004
446
0.180
Why?
Hypnosis
2
2006
16
0.180
Why?
Information Services
1
2009
24
0.180
Why?
Diabetes Mellitus, Type 2
1
2012
222
0.180
Why?
Community Health Services
2
2006
80
0.170
Why?
Insulin-Like Growth Factor I
1
2010
106
0.170
Why?
Blood-Brain Barrier
1
2010
110
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.170
Why?
Placebos
2
2005
185
0.170
Why?
Gene Expression Regulation, Neoplastic
1
2011
266
0.170
Why?
Adolescent
6
1989
5044
0.160
Why?
Awareness
1
2008
34
0.160
Why?
Pregnancy
2
2002
1941
0.160
Why?
Sickness Impact Profile
1
2007
40
0.150
Why?
Cognition Disorders
1
2011
291
0.150
Why?
Survivors
2
2004
118
0.150
Why?
Stress, Psychological
1
2011
290
0.150
Why?
Young Adult
2
2009
1084
0.150
Why?
Cognition
1
2009
232
0.150
Why?
Incidence
1
2009
682
0.150
Why?
Placebo Effect
1
2006
36
0.140
Why?
Administration, Oral
2
2003
314
0.140
Why?
Acupuncture Points
1
2005
2
0.140
Why?
Serotonin
2
2001
102
0.140
Why?
Choice Behavior
1
2006
51
0.130
Why?
Menopause
1
2005
38
0.130
Why?
Models, Psychological
1
2006
92
0.130
Why?
Motion Sickness
1
2004
8
0.130
Why?
Sex Factors
3
1997
613
0.130
Why?
Tai Ji
1
2004
22
0.120
Why?
Chronic Disease
1
2007
554
0.120
Why?
Exercise
1
2006
181
0.120
Why?
Analysis of Variance
4
2003
749
0.120
Why?
Decision Making
1
2006
227
0.120
Why?
Serotonin Uptake Inhibitors
1
2003
35
0.120
Why?
Combined Modality Therapy
1
2005
491
0.110
Why?
Demography
3
2006
103
0.110
Why?
Receptors, Serotonin
2
1998
12
0.110
Why?
New England
1
2002
25
0.110
Why?
Pregnancy Complications
1
2004
191
0.110
Why?
Cross-Over Studies
1
2002
119
0.110
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2001
6
0.100
Why?
Affect
1
2001
78
0.100
Why?
Patients
1
2001
48
0.100
Why?
Health Surveys
3
2004
234
0.100
Why?
Circadian Rhythm
1
2001
85
0.100
Why?
Reference Values
1
2002
453
0.100
Why?
Time Factors
5
1986
3234
0.090
Why?
Multivariate Analysis
1
2002
548
0.090
Why?
Ovarian Neoplasms
1
2000
106
0.090
Why?
Self-Assessment
2
2006
51
0.080
Why?
Regression Analysis
1
2000
539
0.080
Why?
Follow-Up Studies
4
1989
1889
0.080
Why?
Diabetic Nephropathies
1
1997
22
0.080
Why?
Permeability
1
1997
84
0.080
Why?
Asian Continental Ancestry Group
1
1997
29
0.080
Why?
Carcinoma
1
1999
194
0.080
Why?
Patient Acceptance of Health Care
2
2008
123
0.080
Why?
Weight Loss
2
2004
79
0.080
Why?
Biological Transport
1
1997
399
0.070
Why?
African Continental Ancestry Group
1
1997
125
0.070
Why?
Animals
2
2010
16416
0.070
Why?
Prostatic Neoplasms
1
2002
540
0.070
Why?
Palliative Care
1
1998
161
0.070
Why?
Ethnic Groups
1
1997
160
0.070
Why?
Social Support
2
2004
233
0.070
Why?
Longitudinal Studies
2
2005
413
0.070
Why?
Physician-Patient Relations
3
2000
379
0.070
Why?
European Continental Ancestry Group
1
1997
238
0.070
Why?
United States
3
2006
2847
0.070
Why?
Attitude to Health
2
2006
228
0.060
Why?
Prevalence
2
2002
582
0.060
Why?
Dose-Response Relationship, Drug
2
2001
1142
0.060
Why?
General Practice
1
2012
1
0.050
Why?
Directive Counseling
1
2012
6
0.050
Why?
Patient Preference
1
2012
9
0.050
Why?
Dentistry
1
2012
19
0.050
Why?
New York
2
2006
1378
0.050
Why?
Qualitative Research
1
2012
56
0.050
Why?
Self Care
1
2012
60
0.050
Why?
Indiana
1
2011
6
0.050
Why?
Massage
1
2011
9
0.050
Why?
Interviews as Topic
1
2012
189
0.050
Why?
Factor Analysis, Statistical
1
2011
57
0.050
Why?
Interleukin-8
1
2011
111
0.050
Why?
Patient Care Team
1
2012
199
0.050
Why?
Bromodeoxyuridine
1
2010
68
0.050
Why?
Energy Metabolism
1
2011
137
0.050
Why?
Neurogenesis
1
2010
30
0.050
Why?
Chemokine CCL2
1
2011
128
0.050
Why?
Fluorouracil
1
2010
78
0.050
Why?
Paclitaxel
1
2010
59
0.050
Why?
Psychometrics
1
2011
232
0.040
Why?
Outpatients
1
2009
31
0.040
Why?
Glomerulonephritis, Membranous
1
1989
2
0.040
Why?
Confidence Intervals
1
2009
164
0.040
Why?
Memory
1
2009
104
0.040
Why?
Interleukin-6
1
2011
339
0.040
Why?
Health Behavior
1
2009
115
0.040
Why?
Needs Assessment
1
2009
100
0.040
Why?
Health Services Needs and Demand
1
2009
114
0.040
Why?
Prednisone
1
1989
182
0.040
Why?
National Cancer Institute (U.S.)
1
2007
12
0.040
Why?
Odds Ratio
1
2009
323
0.040
Why?
Attention
1
2009
151
0.040
Why?
Reproducibility of Results
1
2011
903
0.040
Why?
Quality Indicators, Health Care
1
2007
62
0.040
Why?
Sulfinpyrazone
1
1986
2
0.040
Why?
Cognitive Therapy
1
2007
41
0.040
Why?
Argininosuccinic Acid
1
1986
3
0.040
Why?
Mitomycins
1
1986
17
0.040
Why?
Plasmapheresis
1
1986
26
0.040
Why?
National Institutes of Health (U.S.)
1
2006
64
0.040
Why?
Cancer Care Facilities
1
2006
12
0.040
Why?
Cell Proliferation
1
2010
520
0.030
Why?
Radiotherapy, Adjuvant
1
2006
74
0.030
Why?
Chemotherapy, Adjuvant
1
2006
88
0.030
Why?
Arginine
1
1986
120
0.030
Why?
Program Evaluation
1
2006
225
0.030
Why?
Electric Stimulation Therapy
1
2005
29
0.030
Why?
Radiation Dosage
1
2005
122
0.030
Why?
Alopecia
1
2004
22
0.030
Why?
Mice, Inbred C57BL
1
2010
1700
0.030
Why?
Antidepressive Agents
1
2005
93
0.030
Why?
Acute Disease
1
2005
591
0.030
Why?
Psychotherapy
1
2005
88
0.030
Why?
Self Concept
1
2004
107
0.030
Why?
Educational Status
1
2004
182
0.030
Why?
Blood Platelets
1
1986
281
0.030
Why?
Glucocorticoids
1
2005
168
0.030
Why?
Randomized Controlled Trials as Topic
1
2005
415
0.030
Why?
Communication
1
2006
282
0.030
Why?
Chi-Square Distribution
1
2003
347
0.030
Why?
Psychiatric Status Rating Scales
1
2003
332
0.030
Why?
Hospitals, Chronic Disease
1
2001
2
0.030
Why?
Ontario
1
2001
12
0.030
Why?
Neurons
1
2010
1105
0.030
Why?
Behavioral Medicine
1
2001
11
0.030
Why?
Peritonitis
1
2001
34
0.030
Why?
Infection
1
2001
67
0.030
Why?
Health Status Indicators
1
2002
112
0.030
Why?
Vagus Nerve
1
2001
39
0.030
Why?
Pituitary-Adrenal System
1
2001
36
0.030
Why?
Autonomic Nervous System
1
2001
70
0.020
Why?
Hypothalamo-Hypophyseal System
1
2001
55
0.020
Why?
Catheters, Indwelling
1
2001
69
0.020
Why?
Anemia
1
2001
78
0.020
Why?
Sampling Studies
1
2000
50
0.020
Why?
Professional-Patient Relations
1
2000
45
0.020
Why?
Breast Neoplasms, Male
1
1999
6
0.020
Why?
Informed Consent
1
2000
86
0.020
Why?
Adenosine Triphosphate
1
2001
415
0.020
Why?
Data Collection
1
2000
231
0.020
Why?
Emetics
1
1998
4
0.020
Why?
Mice
1
2010
6206
0.020
Why?
Cytokines
1
2001
575
0.020
Why?
Creatinine
2
1986
131
0.020
Why?
Sensitivity and Specificity
1
2000
914
0.020
Why?
Retrospective Studies
1
2001
2302
0.020
Why?
Proteinuria
1
1989
30
0.010
Why?
Random Allocation
1
1989
253
0.010
Why?
Tablets, Enteric-Coated
1
1986
2
0.010
Why?
Dipyridamole
1
1986
10
0.010
Why?
Mitomycin
1
1986
18
0.010
Why?
Prospective Studies
1
1989
1696
0.010
Why?
Adenocarcinoma
1
1986
483
0.010
Why?

Visualizations


Roscoe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department